Tramadol Hydrochloride Tablet, Film Coated
Product Images NDC 16571-716

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 16571-716). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Tramadol Fig1)

FDA Label Image

Clinical Studies Section (Tramadol Fig2)

This appears to be a chart showing the percent of patients discontinuing the CAPSS-047 protocol due to nausea/vomiting over a period of 20 days. The X-axis shows the days in the double-blind protocol, while the Y-axis shows the percentage of patients discontinuing. There is a specific point marked at 10 days when patients were taking 200 mg/day.*

FDA Label Image

Tramadol-fig3 (Tramadol Fig3)

The text is a medication label for PURiSINg Tramadol hydrochloride tablets. Each tablet contains 50 mg of tramadol hydrochloride USP. It includes dosage information, storage instructions, and a warning to keep the medicine out of reach of children. There is a separate medication guide to be given to each patient. The label also provides information on the manufacturer, distributor, and batch coding.*

FDA Label Image

Structure (Tramadol Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.